Infobird and HYCAN, a New EV Brand in China, Partner to Promote a Digital Marketing Solution for this Rapidly Growing New Energy Vehicle Brand

Cooperation marks a milestone for Infobird’s digital marketing solution in the New Energy Vehicle industry BEIJING, Dec. 20, 2021 /PRNewswire/ — Infobird Co., Ltd (Nasdaq: IFBD) (“Infobird” or the “Company”), a software-as-a-service provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China, announced today it had entered into a service agreement with HYCAN, a New […]

Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty Patients

New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University Hospital MIAMI, Nov. 30, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that it has entered into […]

Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.

Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disorders MIAMI BEACH, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new […]

U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

Phase 2 clinical trial underway for Hypoplastic Left Heart Syndrome, which affects approximately 1,000 babies per year MIAMI, Nov. 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food and Drug Administration (FDA) […]

Muscle Maker, Inc. Posts Another Triple Digit Revenue Increase in Q3, Improving Financial Results

Health-focused restaurant company experiences 190% revenue gains as the integration of recent acquisitions begins to be reported League City, Texas, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Muscle Maker, Inc. (Nasdaq: GRIL), the parent company of Muscle Maker Grill, Pokemoto and Superfit Foods, today announced the posting of its third quarter 2021 financial results on November […]

Applied UV Reports Third Quarter 2021 Results

Results: Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs. sales in the previous quarter Net loss improved 49% to $(1,080,805) as compared to a net loss of $(2,138,231) in the previous quarter […]

Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT

NEW YORK, Nov. 16, 2021 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has signed a Sponsored Research Agreement with North Carolina State University (“NC State“) to support the continued research and development of HT-KIT, a novel therapeutic for the treatment mast cell cancers. The research will be led by Dr. Glenn Cruse, Assistant Professor, and […]

Gaucho Group Holdings Announces First Vineyard Estate Lot Sale in Cryptocurrency

Luxury Real Estate Development Expands Diversification Opportunity for Global Investors NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Gaucho Group Holdings, Inc. (NASDAQ:VINO), a company that includes a growing collection of e-commerce platforms with a concentration on fine wines, luxury real estate, and leather goods & accessories, today announced its luxury residential vineyard real estate […]

Quipt Continues National Expansion With Closing of Strategic Acquisition in Central Illinois and Ongoing Business Momentum as Respiratory Equipment Demand Remains Elevated Into Fiscal Q1 2022

$2.5 Million in Annualized Revenues, 25% Projected Adjusted EBITDA Margin Post Integration, and Adds Over 3,700 Active Patients Quipt Has Completed 6 Acquisitions for Over $16 Million in Revenue, Adding Over 30,000 Active Patients Since July CINCINNATI, Nov. 09, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.